-
Study aim
-
The aim of this study is to investigate the impact of subcutaneous ketamine versus subcutaneous dexamethasone on pain following elective cesarean
-
Design
-
This study will include 93 candidates for elective cesarean surgery who meet the inclusion criteria. The candidates will be randomly divided into three groups, each consisting of 31 people, using block division.
-
Settings and conduct
-
In the first intervention group, 0.5 mg of diluted ketamine weight will be injected subcutaneously at the caesarean incision site while closing the skin, and in the second intervention group, 16 mg of dexamethasone will be injected subcutaneously in the same way. The control group will not receive any additional intervention. Pain intensity will be recorded at 0 , 2, 6, 12, and 24 hours after surgery based on the visual pain scale. This study was conducted in Ayatollah Mousavi Hospital, Zanjan, in a double-blind manner, and the data collector and the analyst will not know about the patient group.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
ASA class 1 or 2
Age between 18-45 years
Single term pregnancy
Candidate for non-emergency cesarean surgery
Insensitivity to ketamine and dexamethasone
No history of chronic pain, neurological and mental diseases, cardiovascular diseases
Not receiving any kind of pain medication in the last 24 hours
-
Intervention groups
-
In the first intervention group, 0.5 mg of diluted ketamine will be injected subcutaneously at the cesarean incision site at the end of the surgery while closing the skin. In the second intervention group, 16 mg of dexamethasone will be injected subcutaneously in the same way at the cesarean incision site. The third group, or control group, will not receive any additional intervention.
-
Main outcome variables
-
The time of requesting the first dose of painkillers, the amount and frequency of painkillers in the first 24 hours after surgery